Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
WNT SIGNALING PATHWAY |
24 |
351 |
3.7e-35 |
1.721e-31 |
2 |
REGULATION OF WNT SIGNALING PATHWAY |
17 |
310 |
2.04e-22 |
4.746e-19 |
3 |
CANONICAL WNT SIGNALING PATHWAY |
12 |
95 |
3.232e-20 |
5.012e-17 |
4 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
14 |
236 |
7.775e-19 |
9.044e-16 |
5 |
NON CANONICAL WNT SIGNALING PATHWAY |
12 |
140 |
4.116e-18 |
3.307e-15 |
6 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
13 |
197 |
4.265e-18 |
3.307e-15 |
7 |
REGULATION OF EMBRYONIC DEVELOPMENT |
10 |
114 |
2.829e-15 |
1.88e-12 |
8 |
REGULATION OF ORGAN MORPHOGENESIS |
12 |
242 |
3.247e-15 |
1.889e-12 |
9 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
20 |
1672 |
1.107e-13 |
4.683e-11 |
10 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
10 |
162 |
1.019e-13 |
4.683e-11 |
11 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
17 |
1021 |
9.776e-14 |
4.683e-11 |
12 |
REGULATION OF CELL DIFFERENTIATION |
19 |
1492 |
2.147e-13 |
8.325e-11 |
13 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
17 |
1142 |
6.01e-13 |
2.151e-10 |
14 |
CELL FATE COMMITMENT |
10 |
227 |
3.006e-12 |
9.325e-10 |
15 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
9 |
152 |
2.971e-12 |
9.325e-10 |
16 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
8 |
110 |
1.042e-11 |
3.032e-09 |
17 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
14 |
823 |
2.314e-11 |
6.334e-09 |
18 |
NEURON DIFFERENTIATION |
14 |
874 |
5.145e-11 |
1.33e-08 |
19 |
POSITIVE REGULATION OF CELL COMMUNICATION |
17 |
1532 |
6.555e-11 |
1.605e-08 |
20 |
EMBRYO DEVELOPMENT |
14 |
894 |
6.943e-11 |
1.615e-08 |
21 |
MIDBRAIN DEVELOPMENT |
7 |
90 |
1.436e-10 |
3.182e-08 |
22 |
NEUROGENESIS |
16 |
1402 |
2.057e-10 |
4.351e-08 |
23 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
18 |
1929 |
2.348e-10 |
4.75e-08 |
24 |
ORGAN MORPHOGENESIS |
13 |
841 |
4.792e-10 |
9.142e-08 |
25 |
RESPONSE TO RETINOIC ACID |
7 |
107 |
4.912e-10 |
9.142e-08 |
26 |
TISSUE MORPHOGENESIS |
11 |
533 |
7.138e-10 |
1.277e-07 |
27 |
EMBRYONIC MORPHOGENESIS |
11 |
539 |
8.031e-10 |
1.384e-07 |
28 |
DOPAMINERGIC NEURON DIFFERENTIATION |
5 |
28 |
9.979e-10 |
1.658e-07 |
29 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
11 |
554 |
1.072e-09 |
1.662e-07 |
30 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
7 |
119 |
1.04e-09 |
1.662e-07 |
31 |
CELLULAR RESPONSE TO RETINOIC ACID |
6 |
65 |
1.165e-09 |
1.749e-07 |
32 |
REGULATION OF ORGAN FORMATION |
5 |
32 |
2.035e-09 |
2.959e-07 |
33 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
14 |
1192 |
2.988e-09 |
4.213e-07 |
34 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
16 |
1710 |
3.787e-09 |
5.182e-07 |
35 |
SENSORY ORGAN MORPHOGENESIS |
8 |
239 |
5.137e-09 |
6.829e-07 |
36 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
15 |
1492 |
5.498e-09 |
7.106e-07 |
37 |
WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY |
5 |
39 |
5.769e-09 |
7.254e-07 |
38 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
7 |
154 |
6.323e-09 |
7.743e-07 |
39 |
RESPONSE TO LIPID |
12 |
888 |
1.211e-08 |
1.444e-06 |
40 |
HEAD DEVELOPMENT |
11 |
709 |
1.398e-08 |
1.626e-06 |
41 |
CELLULAR RESPONSE TO ACID CHEMICAL |
7 |
175 |
1.535e-08 |
1.742e-06 |
42 |
MORPHOGENESIS OF AN EPITHELIUM |
9 |
400 |
1.577e-08 |
1.748e-06 |
43 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
14 |
1360 |
1.619e-08 |
1.752e-06 |
44 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
13 |
1135 |
1.794e-08 |
1.897e-06 |
45 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
14 |
1381 |
1.967e-08 |
2.034e-06 |
46 |
PATTERN SPECIFICATION PROCESS |
9 |
418 |
2.306e-08 |
2.332e-06 |
47 |
EPITHELIUM DEVELOPMENT |
12 |
945 |
2.416e-08 |
2.392e-06 |
48 |
STEM CELL DIFFERENTIATION |
7 |
190 |
2.707e-08 |
2.624e-06 |
49 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
5 |
56 |
3.749e-08 |
3.56e-06 |
50 |
RESPONSE TO ACID CHEMICAL |
8 |
319 |
4.857e-08 |
4.455e-06 |
51 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
11 |
801 |
4.883e-08 |
4.455e-06 |
52 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
12 |
1036 |
6.655e-08 |
5.734e-06 |
53 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
15 |
1791 |
6.468e-08 |
5.734e-06 |
54 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
12 |
1036 |
6.655e-08 |
5.734e-06 |
55 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
6 |
134 |
9.318e-08 |
7.868e-06 |
56 |
SENSORY ORGAN DEVELOPMENT |
9 |
493 |
9.47e-08 |
7.868e-06 |
57 |
EYE MORPHOGENESIS |
6 |
136 |
1.018e-07 |
8.308e-06 |
58 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
11 |
872 |
1.157e-07 |
9.281e-06 |
59 |
AXIS ELONGATION |
4 |
27 |
1.188e-07 |
9.369e-06 |
60 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
9 |
513 |
1.328e-07 |
1.03e-05 |
61 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
8 |
365 |
1.367e-07 |
1.043e-05 |
62 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
14 |
1618 |
1.44e-07 |
1.081e-05 |
63 |
NEURAL TUBE DEVELOPMENT |
6 |
149 |
1.75e-07 |
1.292e-05 |
64 |
SOMITE DEVELOPMENT |
5 |
78 |
2.018e-07 |
1.467e-05 |
65 |
TUBE DEVELOPMENT |
9 |
552 |
2.467e-07 |
1.766e-05 |
66 |
REGULATION OF JNK CASCADE |
6 |
159 |
2.569e-07 |
1.811e-05 |
67 |
POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT |
4 |
33 |
2.75e-07 |
1.91e-05 |
68 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
11 |
957 |
2.95e-07 |
2.018e-05 |
69 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
10 |
750 |
3e-07 |
2.023e-05 |
70 |
PALATE DEVELOPMENT |
5 |
85 |
3.109e-07 |
2.04e-05 |
71 |
BRAIN MORPHOGENESIS |
4 |
34 |
3.113e-07 |
2.04e-05 |
72 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
6 |
166 |
3.313e-07 |
2.141e-05 |
73 |
CELL CELL SIGNALING |
10 |
767 |
3.687e-07 |
2.35e-05 |
74 |
REGULATION OF CELL DEATH |
13 |
1472 |
3.782e-07 |
2.378e-05 |
75 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
7 |
285 |
4.29e-07 |
2.661e-05 |
76 |
REGULATION OF CELL PROLIFERATION |
13 |
1496 |
4.556e-07 |
2.789e-05 |
77 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
10 |
788 |
4.726e-07 |
2.819e-05 |
78 |
CIRCULATORY SYSTEM DEVELOPMENT |
10 |
788 |
4.726e-07 |
2.819e-05 |
79 |
NEURAL TUBE FORMATION |
5 |
94 |
5.146e-07 |
3.031e-05 |
80 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
10 |
799 |
5.366e-07 |
3.095e-05 |
81 |
TISSUE DEVELOPMENT |
13 |
1518 |
5.388e-07 |
3.095e-05 |
82 |
POSITIVE REGULATION OF CELL PROLIFERATION |
10 |
814 |
6.361e-07 |
3.61e-05 |
83 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
4 |
42 |
7.441e-07 |
4.026e-05 |
84 |
POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
3 |
11 |
7.338e-07 |
4.026e-05 |
85 |
MESENCHYME DEVELOPMENT |
6 |
190 |
7.321e-07 |
4.026e-05 |
86 |
CAMERA TYPE EYE MORPHOGENESIS |
5 |
101 |
7.363e-07 |
4.026e-05 |
87 |
CELLULAR RESPONSE TO LIPID |
8 |
457 |
7.532e-07 |
4.028e-05 |
88 |
REGIONALIZATION |
7 |
311 |
7.711e-07 |
4.077e-05 |
89 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
6 |
197 |
9.046e-07 |
4.729e-05 |
90 |
TUBE MORPHOGENESIS |
7 |
323 |
9.933e-07 |
5.135e-05 |
91 |
EYE DEVELOPMENT |
7 |
326 |
1.057e-06 |
5.402e-05 |
92 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
4 |
48 |
1.284e-06 |
6.426e-05 |
93 |
CELL PROLIFERATION |
9 |
672 |
1.277e-06 |
6.426e-05 |
94 |
HEART MORPHOGENESIS |
6 |
212 |
1.387e-06 |
6.868e-05 |
95 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE |
3 |
14 |
1.613e-06 |
7.659e-05 |
96 |
CELLULAR COMPONENT MORPHOGENESIS |
10 |
900 |
1.585e-06 |
7.659e-05 |
97 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
9 |
691 |
1.609e-06 |
7.659e-05 |
98 |
CONVERGENT EXTENSION |
3 |
14 |
1.613e-06 |
7.659e-05 |
99 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
12 |
1395 |
1.639e-06 |
7.701e-05 |
100 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
11 |
1152 |
1.849e-06 |
8.603e-05 |
101 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
4 |
53 |
1.921e-06 |
8.823e-05 |
102 |
FOREBRAIN DEVELOPMENT |
7 |
357 |
1.934e-06 |
8.823e-05 |
103 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
6 |
228 |
2.116e-06 |
9.561e-05 |
104 |
POSITIVE REGULATION OF GENE EXPRESSION |
13 |
1733 |
2.424e-06 |
0.0001084 |
105 |
TUBE FORMATION |
5 |
129 |
2.473e-06 |
0.0001087 |
106 |
PARAXIAL MESODERM DEVELOPMENT |
3 |
16 |
2.476e-06 |
0.0001087 |
107 |
MESENCHYMAL CELL DIFFERENTIATION |
5 |
134 |
2.982e-06 |
0.0001297 |
108 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
5 |
135 |
3.093e-06 |
0.0001332 |
109 |
SOMITOGENESIS |
4 |
62 |
3.621e-06 |
0.0001532 |
110 |
POST ANAL TAIL MORPHOGENESIS |
3 |
18 |
3.599e-06 |
0.0001532 |
111 |
REGULATION OF TRANSPORT |
13 |
1804 |
3.798e-06 |
0.0001592 |
112 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
12 |
1518 |
3.971e-06 |
0.000165 |
113 |
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
3 |
19 |
4.269e-06 |
0.0001743 |
114 |
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
3 |
19 |
4.269e-06 |
0.0001743 |
115 |
EMBRYONIC ORGAN DEVELOPMENT |
7 |
406 |
4.521e-06 |
0.0001829 |
116 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
7 |
408 |
4.669e-06 |
0.0001841 |
117 |
MESODERM MORPHOGENESIS |
4 |
66 |
4.655e-06 |
0.0001841 |
118 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
4 |
66 |
4.655e-06 |
0.0001841 |
119 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
13 |
1848 |
4.965e-06 |
0.0001941 |
120 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
5 |
152 |
5.529e-06 |
0.000214 |
121 |
SYNAPSE ASSEMBLY |
4 |
69 |
5.564e-06 |
0.000214 |
122 |
NEURAL PRECURSOR CELL PROLIFERATION |
4 |
70 |
5.894e-06 |
0.0002248 |
123 |
GASTRULATION |
5 |
155 |
6.082e-06 |
0.0002301 |
124 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
8 |
609 |
6.363e-06 |
0.0002388 |
125 |
EMBRYONIC ORGAN MORPHOGENESIS |
6 |
279 |
6.764e-06 |
0.0002518 |
126 |
REGULATION OF CELL DEVELOPMENT |
9 |
836 |
7.625e-06 |
0.0002816 |
127 |
REGULATION OF DEVELOPMENTAL GROWTH |
6 |
289 |
8.271e-06 |
0.000303 |
128 |
REGULATION OF BMP SIGNALING PATHWAY |
4 |
77 |
8.627e-06 |
0.0003136 |
129 |
NEGATIVE REGULATION OF CELL DEATH |
9 |
872 |
1.071e-05 |
0.0003862 |
130 |
HEART DEVELOPMENT |
7 |
466 |
1.112e-05 |
0.0003979 |
131 |
REGULATION OF MAPK CASCADE |
8 |
660 |
1.144e-05 |
0.0004033 |
132 |
NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT |
3 |
26 |
1.136e-05 |
0.0004033 |
133 |
POSITIVE REGULATION OF MAPK CASCADE |
7 |
470 |
1.175e-05 |
0.0004111 |
134 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
4 |
84 |
1.22e-05 |
0.0004235 |
135 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
4 |
85 |
1.278e-05 |
0.0004374 |
136 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
3 |
27 |
1.277e-05 |
0.0004374 |
137 |
POSITIVE REGULATION OF KINASE ACTIVITY |
7 |
482 |
1.383e-05 |
0.0004699 |
138 |
VENTRICULAR SEPTUM MORPHOGENESIS |
3 |
28 |
1.428e-05 |
0.0004816 |
139 |
CELL DEVELOPMENT |
11 |
1426 |
1.44e-05 |
0.000482 |
140 |
REGULATION OF STEM CELL PROLIFERATION |
4 |
88 |
1.467e-05 |
0.0004876 |
141 |
SEGMENTATION |
4 |
89 |
1.534e-05 |
0.0005063 |
142 |
AXIS SPECIFICATION |
4 |
90 |
1.604e-05 |
0.0005255 |
143 |
DORSAL VENTRAL PATTERN FORMATION |
4 |
91 |
1.675e-05 |
0.0005451 |
144 |
POSITIVE REGULATION OF CELL CYCLE |
6 |
332 |
1.817e-05 |
0.0005872 |
145 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
6 |
337 |
1.977e-05 |
0.0006344 |
146 |
REGULATION OF ENDOCYTOSIS |
5 |
199 |
2.041e-05 |
0.0006504 |
147 |
REGULATION OF CELL CYCLE |
9 |
949 |
2.104e-05 |
0.0006661 |
148 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
12 |
1805 |
2.339e-05 |
0.0007352 |
149 |
EMBRYONIC AXIS SPECIFICATION |
3 |
33 |
2.365e-05 |
0.0007386 |
150 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
11 |
1517 |
2.575e-05 |
0.0007984 |
151 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
3 |
34 |
2.591e-05 |
0.0007984 |
152 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
4 |
102 |
2.629e-05 |
0.0008047 |
153 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
4 |
103 |
2.732e-05 |
0.0008254 |
154 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
4 |
103 |
2.732e-05 |
0.0008254 |
155 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
9 |
983 |
2.78e-05 |
0.0008347 |
156 |
CARDIAC CHAMBER MORPHOGENESIS |
4 |
104 |
2.838e-05 |
0.000841 |
157 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
4 |
104 |
2.838e-05 |
0.000841 |
158 |
RESPONSE TO ALCOHOL |
6 |
362 |
2.956e-05 |
0.0008705 |
159 |
REGULATION OF FAT CELL DIFFERENTIATION |
4 |
106 |
3.058e-05 |
0.000895 |
160 |
REGULATION OF RECEPTOR INTERNALIZATION |
3 |
37 |
3.353e-05 |
0.000975 |
161 |
REGULATION OF NEURON DIFFERENTIATION |
7 |
554 |
3.383e-05 |
0.0009776 |
162 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
8 |
771 |
3.502e-05 |
0.001006 |
163 |
FORMATION OF PRIMARY GERM LAYER |
4 |
110 |
3.537e-05 |
0.00101 |
164 |
MESENCHYME MORPHOGENESIS |
3 |
38 |
3.636e-05 |
0.001032 |
165 |
REGULATION OF KINASE ACTIVITY |
8 |
776 |
3.667e-05 |
0.001034 |
166 |
REGULATION OF SYNAPSE ORGANIZATION |
4 |
113 |
3.931e-05 |
0.001102 |
167 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
5 |
232 |
4.254e-05 |
0.001185 |
168 |
MAMMARY GLAND DEVELOPMENT |
4 |
117 |
4.504e-05 |
0.001248 |
169 |
NEGATIVE REGULATION OF GROWTH |
5 |
236 |
4.614e-05 |
0.00127 |
170 |
MESODERM DEVELOPMENT |
4 |
118 |
4.657e-05 |
0.001275 |
171 |
GLAND DEVELOPMENT |
6 |
395 |
4.811e-05 |
0.001309 |
172 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
4 |
121 |
5.137e-05 |
0.00139 |
173 |
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION |
3 |
43 |
5.288e-05 |
0.001422 |
174 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
7 |
602 |
5.731e-05 |
0.001532 |
175 |
POSITIVE REGULATION OF CELL DEATH |
7 |
605 |
5.913e-05 |
0.001572 |
176 |
OSTEOBLAST DIFFERENTIATION |
4 |
126 |
6.016e-05 |
0.001591 |
177 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
7 |
616 |
6.624e-05 |
0.001741 |
178 |
DIGESTIVE TRACT MORPHOGENESIS |
3 |
48 |
7.368e-05 |
0.001926 |
179 |
NEGATIVE REGULATION OF LOCOMOTION |
5 |
263 |
7.71e-05 |
0.002004 |
180 |
REGULATION OF GROWTH |
7 |
633 |
7.86e-05 |
0.002019 |
181 |
MUSCLE STRUCTURE DEVELOPMENT |
6 |
432 |
7.899e-05 |
0.002019 |
182 |
CARDIAC SEPTUM MORPHOGENESIS |
3 |
49 |
7.839e-05 |
0.002019 |
183 |
SEX DIFFERENTIATION |
5 |
266 |
8.134e-05 |
0.002068 |
184 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
6 |
437 |
8.416e-05 |
0.002128 |
185 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
8 |
876 |
8.627e-05 |
0.00217 |
186 |
RESPONSE TO EXTRACELLULAR STIMULUS |
6 |
441 |
8.848e-05 |
0.002214 |
187 |
RESPONSE TO HORMONE |
8 |
893 |
9.866e-05 |
0.002455 |
188 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
3 |
53 |
9.922e-05 |
0.002456 |
189 |
CARDIAC CHAMBER DEVELOPMENT |
4 |
144 |
0.0001011 |
0.002475 |
190 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
4 |
144 |
0.0001011 |
0.002475 |
191 |
RESPONSE TO ENDOGENOUS STIMULUS |
10 |
1450 |
0.0001017 |
0.002479 |
192 |
SYNAPSE ORGANIZATION |
4 |
145 |
0.0001038 |
0.002515 |
193 |
SKELETAL SYSTEM DEVELOPMENT |
6 |
455 |
0.0001051 |
0.00252 |
194 |
VENTRICULAR SEPTUM DEVELOPMENT |
3 |
54 |
0.0001049 |
0.00252 |
195 |
RESPONSE TO ESTRADIOL |
4 |
146 |
0.0001066 |
0.002543 |
196 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
8 |
905 |
0.0001083 |
0.00257 |
197 |
REGULATION OF RESPONSE TO STRESS |
10 |
1468 |
0.0001128 |
0.00265 |
198 |
MALE SEX DIFFERENTIATION |
4 |
148 |
0.0001123 |
0.00265 |
199 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
6 |
462 |
0.0001142 |
0.002671 |
200 |
REGULATION OF GTPASE ACTIVITY |
7 |
673 |
0.0001153 |
0.002682 |
201 |
OUTFLOW TRACT MORPHOGENESIS |
3 |
56 |
0.000117 |
0.002708 |
202 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
5 |
289 |
0.0001201 |
0.002767 |
203 |
VASCULATURE DEVELOPMENT |
6 |
469 |
0.000124 |
0.002842 |
204 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
6 |
470 |
0.0001255 |
0.002862 |
205 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
6 |
472 |
0.0001284 |
0.002914 |
206 |
NEGATIVE REGULATION OF GENE EXPRESSION |
10 |
1493 |
0.0001298 |
0.002921 |
207 |
EMBRYONIC PATTERN SPECIFICATION |
3 |
58 |
0.0001299 |
0.002921 |
208 |
STEM CELL PROLIFERATION |
3 |
60 |
0.0001438 |
0.003216 |
209 |
PROTEIN PHOSPHORYLATION |
8 |
944 |
0.0001451 |
0.003229 |
210 |
REGULATION OF TRANSFERASE ACTIVITY |
8 |
946 |
0.0001472 |
0.003261 |
211 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
3 |
61 |
0.000151 |
0.00333 |
212 |
POSITIVE REGULATION OF CELL FATE COMMITMENT |
2 |
11 |
0.0001528 |
0.003338 |
213 |
REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN |
2 |
11 |
0.0001528 |
0.003338 |
214 |
REGULATION OF CARTILAGE DEVELOPMENT |
3 |
63 |
0.0001662 |
0.003599 |
215 |
RESPONSE TO CYTOKINE |
7 |
714 |
0.0001663 |
0.003599 |
216 |
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION |
2 |
12 |
0.0001832 |
0.00391 |
217 |
EMBRYONIC CAMERA TYPE EYE FORMATION |
2 |
12 |
0.0001832 |
0.00391 |
218 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
2 |
12 |
0.0001832 |
0.00391 |
219 |
APPENDAGE DEVELOPMENT |
4 |
169 |
0.0001872 |
0.00396 |
220 |
LIMB DEVELOPMENT |
4 |
169 |
0.0001872 |
0.00396 |
221 |
NEGATIVE REGULATION OF CELL GROWTH |
4 |
170 |
0.0001915 |
0.004014 |
222 |
FOREBRAIN GENERATION OF NEURONS |
3 |
66 |
0.0001909 |
0.004014 |
223 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
3 |
67 |
0.0001996 |
0.004147 |
224 |
INTRACELLULAR SIGNAL TRANSDUCTION |
10 |
1572 |
0.0001988 |
0.004147 |
225 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
3 |
68 |
0.0002086 |
0.004314 |
226 |
HEMATOPOIETIC STEM CELL PROLIFERATION |
2 |
13 |
0.0002162 |
0.004433 |
227 |
REGULATION OF CELL FATE SPECIFICATION |
2 |
13 |
0.0002162 |
0.004433 |
228 |
MUSCLE ORGAN MORPHOGENESIS |
3 |
70 |
0.0002273 |
0.004639 |
229 |
DEVELOPMENTAL GROWTH |
5 |
333 |
0.0002324 |
0.004721 |
230 |
POSITIVE REGULATION OF MEIOTIC CELL CYCLE |
2 |
14 |
0.000252 |
0.005011 |
231 |
RESPONSE TO KETONE |
4 |
182 |
0.0002486 |
0.005011 |
232 |
CELL MIGRATION INVOLVED IN GASTRULATION |
2 |
14 |
0.000252 |
0.005011 |
233 |
REGULATION OF PROTEIN KINASE C SIGNALING |
2 |
14 |
0.000252 |
0.005011 |
234 |
CELLULAR RESPONSE TO VITAMIN D |
2 |
14 |
0.000252 |
0.005011 |
235 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
7 |
767 |
0.0002581 |
0.005088 |
236 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
3 |
73 |
0.0002574 |
0.005088 |
237 |
REGULATION OF HYDROLASE ACTIVITY |
9 |
1327 |
0.0002795 |
0.005488 |
238 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
4 |
188 |
0.0002813 |
0.005499 |
239 |
REGULATION OF MESODERM DEVELOPMENT |
2 |
15 |
0.0002905 |
0.005655 |
240 |
REGULATION OF CELL MORPHOGENESIS |
6 |
552 |
0.0002996 |
0.005808 |
241 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
10 |
1656 |
0.000304 |
0.005869 |
242 |
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
3 |
78 |
0.000313 |
0.006018 |
243 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
4 |
194 |
0.0003169 |
0.006069 |
244 |
REGULATION OF SYNAPSE ASSEMBLY |
3 |
79 |
0.000325 |
0.006197 |
245 |
ORGAN INDUCTION |
2 |
16 |
0.0003316 |
0.006273 |
246 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT |
2 |
16 |
0.0003316 |
0.006273 |
247 |
RESPIRATORY SYSTEM DEVELOPMENT |
4 |
197 |
0.000336 |
0.006329 |
248 |
REGULATION OF FIBROBLAST PROLIFERATION |
3 |
81 |
0.0003498 |
0.006537 |
249 |
REGULATION OF JUN KINASE ACTIVITY |
3 |
81 |
0.0003498 |
0.006537 |
250 |
NEGATIVE REGULATION OF STEM CELL PROLIFERATION |
2 |
17 |
0.0003754 |
0.006932 |
251 |
ESTABLISHMENT OF TISSUE POLARITY |
2 |
17 |
0.0003754 |
0.006932 |
252 |
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
2 |
17 |
0.0003754 |
0.006932 |
253 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
3 |
84 |
0.0003893 |
0.00716 |
254 |
CARDIAC SEPTUM DEVELOPMENT |
3 |
85 |
0.0004031 |
0.007383 |
255 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
4 |
207 |
0.0004053 |
0.007383 |
256 |
POSITIVE REGULATION OF CELL ADHESION |
5 |
376 |
0.0004062 |
0.007383 |
257 |
NOTOCHORD DEVELOPMENT |
2 |
18 |
0.0004219 |
0.007609 |
258 |
UTERUS DEVELOPMENT |
2 |
18 |
0.0004219 |
0.007609 |
259 |
SKIN DEVELOPMENT |
4 |
211 |
0.0004357 |
0.007827 |
260 |
LOCOMOTION |
8 |
1114 |
0.0004476 |
0.00801 |
261 |
EPITHELIAL CELL PROLIFERATION |
3 |
89 |
0.0004613 |
0.008224 |
262 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
4 |
216 |
0.0004759 |
0.008452 |
263 |
RESPONSE TO ESTROGEN |
4 |
218 |
0.0004927 |
0.008717 |
264 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
5 |
393 |
0.000497 |
0.008759 |
265 |
INNER EAR MORPHOGENESIS |
3 |
92 |
0.0005083 |
0.008926 |
266 |
RESPONSE TO NITROGEN COMPOUND |
7 |
859 |
0.000512 |
0.008957 |
267 |
DORSAL VENTRAL AXIS SPECIFICATION |
2 |
20 |
0.0005228 |
0.009112 |
268 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
10 |
1784 |
0.0005528 |
0.009597 |
269 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
5 |
406 |
0.0005761 |
0.009965 |